Janet Woodcock

Marijuana could end up being categorized as a Schedule III substance under the Controlled Substances Act (CSA), reported Marijuana Moment, citing a former top Food and Drug Administration (FDA) official. How? Howard Sklamberg, who chaired the FDA's Marijuana Working Group from 2014 to 2017,...

To protect children from inadvertently consuming cannabis-infused snacks, the U.S. Federal Trade Commission (FTC) and Food and Drug Administration (FDA) sent cease and desist letters to six marijuana companies. "Children are more vulnerable than adults to the effects of THC, with many who...

House Committee on Oversight and Accountability chairman James Comer announced the investigation into the Food and Drug Administration’s (FDA) failure to regulate cannabidiol (CBD) products as dietary supplements. What Happened: After organizing a high-level internal working group to examine...

The FDA is renewing a contract with Waterloo University to conduct a marijuana study, reported Cannabis Wire. Since 2019, the FDA and the University have been conducting International Cannabis Policy Study (ICPS), which surveys thousands of people across the U.S. and Canada...

In view of the growing CBD products market, the Food and Drug Administration convened a high-level internal working group to explore potential regulatory pathways for CBD products. In it, the FDA concluded that it would not regulate CBD as a food and dietary supplement ingredient....

The Food and Drug Administration (FDA) issued final guidance, titled “Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research,” outlining its stand on topics relevant to scientists related to the development of human medicinal products containing...

After years of struggling with regulations on marijuana-based products, the Food and Drug Administration (FDA) is signaling that it has found a way to approach the issue. The research on whether legal cannabis is safe in food or supplements is already underway, reported the Wall Street Journal...

Department of Health and Human Services (HHS) Secretary Xavier Becerra said earlier this month that the agency plans to review the status of cannabis as a Schedule I drug following President Joe Biden's historic announcement that he will pardon federal cannabis possession convictions,...

The FDA has appointed Norman Birenbaum to be the its senior public health advisor on cannabis research and regulatory actions, reported Inside Health Policy. Why This Matters This is the first time the FDA has hired a cannabis research and...

The U.S. Food and Drug Administration issued warning letters to five companies for selling products containing delta-8 THC in ways that violate the Federal Food, Drug, and Cosmetic Act. This action is the first time the FDA has issued warning letters for products containing delta-8 THC.  There...

Hand sanitizers kills 99.9 percent of germs and is effective in promoting health and wellness, right? Perhaps if this claim were true the Food and Drug Administration (FDA) wouldn't find it necessary to initiate a probe and ask for new studies on its effectiveness. The Associated Press reported on...

Shares of Sarepta Therapeutics Inc (NASDAQ: SRPT) spiked higher by around 20 percent Thursday morning after The Street's biotech expert Adam Feuerstein penned an article titled "Why Sarepta Can Ultimately Win FDA Drug Approval." Shares of Sarepta were hard hit after a federal...

Major indices continued its decline from yesterday as the Dow suffered a triple digit point loss for the second consecutive day. Positive retail sales data added to an otherwise already convincing case that the economy is strong enough for the Federal Reserve to begin tapering. The Fed's policy...